Lívia Pena Silveira

6PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical mycologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 08, 2024
Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009-2020.

Marina Xavier Teixeira, Adriano Max Moreira Reis, Paula Lana de Miranda Drummond

|Aug 18, 2023
Chemotherapy-Induced Peripheral Neuropathy Impacts Quality of Life and Activities of Daily Living of Brazilian Multiple Myeloma Patients.

Paula Lana de Miranda Drummond, Roberta Márcia Marques Dos Santos, Lívia Pena Silveira

|Jun 06, 2023
Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma.

Mariana Sampaio Rodrigues de Lima, Cristiane Aparecida Menezes de Pádua, Paula Lana de Miranda Drummond

|Jan 27, 2022
Effect of therapeutic regimens and polypharmacy on health-related quality of life of people with multiple myeloma: a cross-sectional study in Belo Horizonte, Brazil.

Jéssica Soares Malta, Paula Lana de Miranda Drummond, Lívia Pena Silveira

|May 12, 2021
Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma.

Jéssica Soares Malta, Lívia Pena Silveira, Paula Lana de Miranda Drummond

|Feb 15, 2021
Adherence to thalidomide in patients with multiple myeloma: A cross-sectional study in a Brazilian metropolis.

Lívia Pena Silveira, Cristiane A Menezes de Pádua, Paula Lana de Miranda Drummond

Pageof 1